Bluejay Diagnostics (BJDX) Current Taxes (2025 - 2026)

Bluejay Diagnostics (BJDX) reported Current Taxes of $40000.0 for Q1 2026, down 67.1% on a YoY basis from $121568.0 in Q1 2025, and down 70.62% sequentially from $136149.0 in Q4 2025.

Bluejay Diagnostics (BJDX) Current Taxes (2025 - 2026) Analysis & Trends

Bluejay Diagnostics (BJDX) has 2 years of Current Taxes data on file, last reported at $40000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Taxes fell 67.1% year-over-year to $40000.0; the trailing twelve-month figure through Mar 2026 stood at $40000.0 (down 67.1% YoY), and the FY2025 full-year result was $136149.0, changed N/A from the prior year.
  • Current Taxes eased to $40000.0 in Q1 2026, from $136149.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $136149.0 in Q4 2025 to a low of $40000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 598.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 476.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 914.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 231.81 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - 194.00 Mn
10 Bluejay Diagnostics 2,754.24 2,754.24 - 40,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 40,000.00
Dec 31, 2025 136,149.00
Sep 30, 2025 68,074.00
Jun 30, 2025 68,074.00
Mar 31, 2025 121,568.00